Ind AS 115 – Key impact for life sciences entities
Jalpa Sonchhatra, Director, Financial Accounting Advisory Services, EY India speaks on the strategies needed to ensure compliance…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Management
Fix DAVA portal, says industry to DGFT
Faced with delays at ports and possible product recalls, industry hopes the DGFT will fix the issues with the DAVA portal as well…
Opportunity for biotech firms to pursue drug candidates targeting metabolic disorders
The GlobalData report found that big pharma companies lag behind small bio-techs in R&D efforts
E-pharmacies in India — Regulatory landscape and challenges
Sarthak Sarin (Principal Associate) and Bharat Gupta (Associate), Khaitan & Co, give an insight on the need for better…
Number of IO trials in China surge by more than 50 per cent in 2016 and 2017
GlobalData identified 819 clinical trials that have been initiated in the last 10 years (2008-17) to investigate I/O drug…
Digital technologies are definitely important in ensuring compliance with GMP standards
Pharma companies these days have to comply with a number of standards as governed by Good Manufacturing Practice (GMP) and FDA…
Legal framework of PV for medicines marketed in India
Rajdutt Shekhar Singh, Partner, Singh & Associates, gives an insight on the status and objective of pharmacovigilance…
Driving change at Novo Nordisk
As Novo Nordisk implements a change strategy to expands its focus from diabetes to other chronic conditions like obesity, it is…
Selling in the new age
In the first of a new series of articles, Mohan G Joshi, international business coach and speaker on sales and leadership,…
E-pharmacies: New rules to the game
The government recently released draft rules to regulate e-pharmacies and their activities. The industry lauds certain measures…
Restructuring Indian pharma distribution market
The current pharma distribution market in India is in a completely erratic state. Dr Piyush Gupta, Associate Director - GNH India,…
Pharmacovigilance in 2020 – future horizons and efficiencies in data acquisition, evaluation and…
To manage the ever increasing volume of information, companies have turned to cost-effective resources. Jeffrey Ho, Principal…
The story of the pill
Is a pill, just a pill? Most definitely not. In the first of a series of six articles, Organisation of Pharmaceutical Producers of…
Pharma formulators diverge on strategy for non-prescription businesses: IndRa Report
Indian formulators seeking growth amid divestment plans by global formulators
Achieving paperless IEC Office, the digital way
Sudhir Patel, Chief Operation and Co-founder, Quinary Clinical Research, in this white paper, discusses the concepts and methods…
Age-related macular degeneration market will rocket to $11.5 bn by 2026
The growth will be driven by new therapies entering the market and a global aging society, which will lead to increasing numbers…
Ongoing trade war with China can harm US biopharma innovation: GlobalData
China currently appears to be in a much better position from a negotiation standpoint, as the Chinese biopharma industry does not…
IoT software and services in pharma sector to be worth $2.4 billion by 2020
The Asia-Pacific region’s robust IoT software and services growth in the pharma sector is primarily driven by the large number of…
Pharma firms ramp up investment in security products to secure critical data
Pharma companies are also deploying some form of backup and archiving, and content and web filtering solutions to store as well as…